A Systems Biology Strategy Reveals Biological Pathways and Plasma Biomarker Candidates for Potentially Toxic Statin-Induced Changes in Muscle

被引:175
作者
Laaksonen, Reijo [1 ]
Katajamaa, Mikko [2 ,3 ]
Paiva, Hannu [4 ]
Sysi-Aho, Marko [5 ]
Saarinen, Lilli [2 ,3 ]
Junni, Paivi [2 ,3 ]
Lutjohann, Dieter [6 ]
Smet, Joel [7 ]
Van Coster, Rudy [7 ]
Seppanen-Laakso, Tuulikki [5 ]
Lehtimaki, Terho [8 ,9 ,10 ]
Soini, Juhani [2 ,3 ]
Oresic, Matej [5 ]
机构
[1] Tampere Univ Hosp, Res Unit, Tampere, Finland
[2] Univ Turku, Turku Ctr Biotechnol, Turku, Finland
[3] Abo Akad Univ, Turku, Finland
[4] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland
[5] VTT Tech Res Ctr Finland, Espoo, Finland
[6] Univ Bonn, Dept Clin Pharmacol, D-5300 Bonn, Germany
[7] Ghent Univ Hosp, Dept Pediat, Div Pediat Neurol & Metab, B-9000 Ghent, Belgium
[8] Tampere Univ Hosp, Dept Clin Chem, Lab Atherosclerosis Genet, FIN-33521 Tampere, Finland
[9] Tampere Univ Hosp, Ctr Lab Med, FIN-33521 Tampere, Finland
[10] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland
来源
PLOS ONE | 2006年 / 1卷 / 01期
基金
芬兰科学院;
关键词
D O I
10.1371/journal.pone.0000097
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background. Aggressive lipid lowering with high doses of statins increases the risk of statin-induced myopathy. However, the cellular mechanisms leading to muscle damage are not known and sensitive biomarkers are needed to identify patients at risk of developing statin-induced serious side effects. Methodology. We performed bioinformatics analysis of whole genome expression profiling of muscle specimens and UPLC/MS based lipidomics analyses of plasma samples obtained in an earlier randomized trial from patients either on high dose simvastatin (80 mg), atorvastatin (40 mg), or placebo. Principal Findings. High dose simvastatin treatment resulted in 111 differentially expressed genes (1.5-fold change and p-value < 0.05), while expression of only one and five genes was altered in the placebo and atorvastatin groups, respectively. The Gene Set Enrichment Analysis identified several affected pathways (23 gene lists with False Discovery Rate q-value < 0.1) in muscle following high dose simvastatin, including eicosanoid synthesis and Phospholipase C pathways. Using lipidomic analysis we identified previously uncharacterized drug-specific changes in the plasma lipid profile despite similar statin-induced changes in plasma LDL-cholesterol. We also found that the plasma lipidomic changes following simvastatin treatment correlate with the muscle expression of the arachidonate 5-lipoxygenase-activating protein. Conclusions. High dose simvastatin affects multiple metabolic and signaling pathways in skeletal muscle, including the pro-inflammatory pathways. Thus, our results demonstrate that clinically used high statin dosages may lead to unexpected metabolic effects in non-hepatic tissues. The lipidomic profiles may serve as highly sensitive biomarkers of statin-induced metabolic alterations in muscle and may thus allow us to identify patients who should be treated with a lower dose to prevent a possible toxicity.
引用
收藏
页数:9
相关论文
共 31 条
[1]   Clinical perspectives of statin-induced rhabdomyolysis [J].
Antons, KA ;
Williams, CD ;
Baker, SK ;
Phillips, PS .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (05) :400-409
[2]   Partial least squares for discrimination [J].
Barker, M ;
Rayens, W .
JOURNAL OF CHEMOMETRICS, 2003, 17 (03) :166-173
[3]   The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags [J].
Brentani, H ;
Caballero, OL ;
Camargo, AA ;
da Silva, AM ;
da Silva, WA ;
Neto, ED ;
Grivet, M ;
Gruber, A ;
Guimaraes, PEM ;
Hide, W ;
Iseli, C ;
Jongeneel, CV ;
Kelso, J ;
Nagai, MA ;
Ojopi, EPB ;
Osorio, EC ;
Reis, EMR ;
Riggins, GJ ;
Simpson, AJG ;
de Souza, S ;
Stevenson, BJ ;
Strausberg, RL ;
Tajara, EH ;
Verjovski-Almeida, S ;
Acencion, ML ;
Bengtsono, MH ;
Bettonip, F ;
Bodmerq, WF ;
Brionesr, MRS ;
Camargos, LP ;
Caveneet, W ;
Ceruttiu, JM ;
Coelho Andradev, LE ;
Costa dos Santosn, PC ;
Costaw, MCR ;
da Silvaw, IT ;
Esteciox, MRH ;
Ferreiraw, KS ;
Furnarit, FB ;
Faria, M ;
Galantep, PAF ;
Guimaraesy, GS ;
Holandaw, AJ ;
Kimuraz, ET ;
Leerkesp, MR ;
Xin, LA ;
Macielu, RMB ;
Martinsbb, EAL ;
Massirero, KB ;
Melor, ASA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (23) :13418-13423
[4]   Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients -: The PRIMO study [J].
Bruckert, E ;
Hayem, G ;
Dejager, S ;
Yau, C ;
Bégaud, B .
CARDIOVASCULAR DRUGS AND THERAPY, 2005, 19 (06) :403-414
[5]   Leukotriene B-4 stimulates the release of arachidonate in human neutrophils via the action of cytosolic phospholipase A(2) [J].
Burke, JR ;
Davern, LB ;
Gregor, KR ;
Tramposch, KM .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1997, 1359 (01) :80-88
[6]   SIMPLS - AN ALTERNATIVE APPROACH TO PARTIAL LEAST-SQUARES REGRESSION [J].
DEJONG, S .
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 1993, 18 (03) :251-263
[7]   REQUIREMENT OF A 5-LIPOXYGENASE-ACTIVATING PROTEIN FOR LEUKOTRIENE SYNTHESIS [J].
DIXON, RAF ;
DIEHL, RE ;
OPAS, E ;
RANDS, E ;
VICKERS, PJ ;
EVANS, JF ;
GILLARD, JW ;
MILLER, DK .
NATURE, 1990, 343 (6255) :282-284
[8]   Least angle regression - Rejoinder [J].
Efron, B ;
Hastie, T ;
Johnstone, I ;
Tibshirani, R .
ANNALS OF STATISTICS, 2004, 32 (02) :494-499
[9]   Plasmalogens: targets for oxidants and major lipophilic antioxidants [J].
Engelmann, B .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2004, 32 :147-150
[10]   A comprehensive classification system for lipids [J].
Fahy, E ;
Subramaniam, S ;
Brown, HA ;
Glass, CK ;
Merrill, AH ;
Murphy, RC ;
Raetz, CRH ;
Russell, DW ;
Seyama, Y ;
Shaw, W ;
Shimizu, T ;
Spener, F ;
van Meer, G ;
VanNieuwenhze, MS ;
White, SH ;
Witztum, JL ;
Dennis, EA .
JOURNAL OF LIPID RESEARCH, 2005, 46 (05) :839-861